Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of VINCERX PHARMA INC
Analyst Grade Summary
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
7
0
0
0
No Price
30.04.2026 19:59
Current Prices from VINCERX PHARMA INC
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
VINC
USD
30.04.2026 19:59
0,01 USD
0,00 USD
NASDAQ
VINC
USD
30.04.2026 19:59
0,01 USD
0,00 USD
Share Float & Liquidity
Free Float90,68 %
Shares Float4,75 M
Shares Outstanding5,23 M
Company Profile for VINCERX PHARMA INC Share
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candidates include VIP217, an oral PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate to treat solid tumors; and VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California.
